Clinical-biologic patterns of metastatic melanoma and their effect on treatment.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Cancer treatment reports

• Publication date

  1985-04-01

• Fields of study

  Medicine

• Identifiers
  PMID 3995510
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Patterned distribution of metastases from malignant melanoma in humans.

  1983cited by this paper
• A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).

  1983cited by this paper
• Treatment of advanced malignant melanoma with vinblastine, bleomycin, and cisplatin.

  1982cited by this paper
• Prognostic factors in metastatic malignant melanoma. The southeastern cancer study group experience

  1982cited by this paper
• Skeletal metastases of melanoma: radiographic, scintigraphic, and clinical review.

  1981cited by this paper
• Distinct lung-colonizing and lung-metastasizing cell populations in B16 mouse melanoma

  1981cited by this paper
• In vitro characteristics of metastatic variant subclones of restricted genetic origin.

  1981cited by this paper
• Vinblastine, infusion, bleomycin, and cis‐dichlorodiammine‐platinum chemotherapy in metastatic melanoma

  1981cited by this paper
• Influence of microenvironment and vascular anatomy on "metastatic" colonization potential of mammary tumors.

  1981cited by this paper
• Pilot study of vinblastine and bleomycin combinations in the treatment of metastatic melanoma.

  1980cited by this paper
• Biologic behavior and treatment of intransit metastasis of melanoma.

  1980cited by this paper
• Clinical presentation, natural history and prognostic factors in advanced malignant melanoma.

  1979cited by this paper
• Malignant melanoma and central nervous system metastases. Incidence, diagnosis, treatment and survival

  1978cited by this paper
• DTIC (NSC-45388) in malignant melanoma: a perspective.

  1976cited by this paper
• Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts.

  1976cited by this paper
• Combination chemotherapy for disseminated malignant melanoma

  1975cited by this paper
• Prognostic correlations and response to treatment in advanced metastatic malignant melanoma.

  1974cited by this paper
• Biological aspects of human malignant melanoma

  1967cited by this paper
• A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.

  1965cited by this paper

• A rational surgical approach to the treatment of distant melanoma metastases.

  2008cites this paper
• [Alpha 2 -interferon therapy in metastasizing malignant melanoma].

  2008cites this paper
• Soft Tissue Metastasis

  2006cites this paper
• Tc-99m MIBI Scintigraphy in a Patient with Primary and Metastatic Malignant Melanoma

  2002cites this paper
• Detecció del gangli sentinella mitjançant limfogammagrafia i sonda de raigs gamma intraoperatòria en pacients amb melanoma maligne

  2001cites this paper
• The shifting patterns of metastatic melanoma.

  2000cites this paper
• Duration of survival for disseminated malignant melanoma: results of a meta-analysis.

  2000cites this paper
• Langzeitergebnisse nach Strahlentherapie beim lokal rezidivierten und metastasierten malignen Melanom

  1999cites this paper
• Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience.

  1999cites this paper
• [Long term results following radiation therapy of locally recurrent and metastatic malignant melanoma].

  1999cites this paper
• Scintigraphic evaluation of malignant melanoma lesions with Tc-99m tetrofosmin.

  1998cites this paper
• Imaging of Soft Tissue Tumors

  1997cites this paper
• Comparison of patient characteristics and outcome between a single-institution phase II trial and a cooperative-group phase II trial with identical eligibility in metastatic melanoma.

  1997cites this paper
• The development of therapeutic vaccines of the management of malignant melanoma.

  1996cites this paper
• Thermoradiotherapy of Malignant Melanoma

  1996cites this paper
• Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology.

  1995cites this paper
• Tumor gangliosides as targets for active specific immunotherapy of melanoma in man.

  1994cites this paper
• Chemotherapy of advanced malignant-melanoma (review).

  1994cites this paper
• Systemic treatment of advanced malignant-melanoma (review).

  1993cites this paper
• The role of surgery in the treatment of nonregionally recurrent melanoma.

  1993cites this paper
• Prolongation of Survival in Metastatic Melanoma After Active Specific Immunotherapy With a New Polyvalent Melanoma Vaccine

  1992cites this paper
• Survival with regional and distant metastases from cutaneous malignant melanoma.

  1991cites this paper
• Prospective evaluation of the use of antigen-specific immune complexes in predicting the development of recurrent melanoma.

  1991cites this paper
• Replating efficiency of metastatic melanoma cells from lymph node and subcutaneous sites does not predict patient survival

  1989cites this paper
• Relapse in the central nervous system in melanoma patients successfully treated with biomodulators.

  1989cites this paper
• Subcutaneous metastases from malignant melanoma: prevalence and findings on CT.

  1989cites this paper
• Progression of Neoplasms Deriving from Pigmented Tissues

  1989cites this paper
• Malignant melanoma: a clinical perspective

  1988cites this paper
• Metastatic patterns in autopsy cases of cutaneous melanoma.

  1988cites this paper
• Cutaneous malignant melanoma (arizona cancer center experience). I. Natural history and prognostic factors influencing survival in patients with stage i disease

  1988cites this paper
• Surgical resection for metastatic melanoma to the lung.

  1988cites this paper